1,2,4-thiadiazol-5(4H)-ones: a new class of selective inhibitors of Trypanosoma cruzi triosephosphate isomerase. Study of the mechanism of inhibition

References

• Schofield CJ, Jannin J, Salvatella R. The future of Chagas disease control. Trends Parasitol 2006;22:583–588.
   PubMed Web of Science ®Google Scholar
• Gómez-Puyou A, Saavedra-Lira E, Becker I, Zubillaga RA, Rojo-Domínguez A, Pérez-Montfort R. Using evolutionary changes to achieve species-specific inhibition of enzyme action–studies with triosephosphate isomerase. Chem Biol 1995;2:847–855.
   PubMedGoogle Scholar
• Velanker SS, Ray SS, Gokhale RS, Suma S, Balaram H, Balaram P et al. Triosephosphate isomerase from Plasmodium falciparum: the crystal structure provides insights into antimalarial drug design. Structure 1997;5:751–761.
   PubMed Web of Science ®Google Scholar
• Cortés-Figueroa AA, Pérez-Torres A, Salaiza N, Cabrera N, Escalona-Montaño A, Rondán A et al. A monoclonal antibody that inhibits Trypanosoma cruzi growth in vitro and its reaction with intracellular triosephosphate isomerase. Parasitol Res 2008;102:635–643.
   PubMedGoogle Scholar
• Maldonado E, Soriano-García M, Moreno A, Cabrera N, Garza-Ramos G, de Gómez-Puyou M et al. Differences in the intersubunit contacts in triosephosphate isomerase from two closely related pathogenic trypanosomes. J Mol Biol 1998;283:193–203.
   PubMedGoogle Scholar
• Waley SG. Refolding of triose phosphate isomerase. Biochem J 1973;135:165–172.
   PubMedGoogle Scholar
• Zabori S, Rudolph R, Jaenicke R. Folding and association of triose phosphate isomerase from rabbit muscle. Z Naturforsch, C, Biosci 1980;35:999–1004.
   PubMedGoogle Scholar
• Olivares-Illana V, Pérez-Montfort R, López-Calahorra F, Costas M, Rodríguez-Romero A, Tuena de Gómez-Puyou M et al. Structural differences in triosephosphate isomerase from different species and discovery of a multitrypanosomatid inhibitor. Biochemistry 2006;45:2556–2560.
   PubMedGoogle Scholar
• Olivares-Illana V, Rodríguez-Romero A, Becker I, Berzunza M, García J, Pérez-Montfort R et al. Perturbation of the dimer interface of triosephosphate isomerase and its effect on Trypanosoma cruzi. PLoS Negl Trop Dis 2007;1:e1.
   PubMed Web of Science ®Google Scholar
• Cardinale D, Salo-Ahen OM, Ferrari S, Ponterini G, Cruciani G, Carosati E et al. Homodimeric enzymes as drug targets. Curr Med Chem 2010;17:826–846.
   PubMed Web of Science ®Google Scholar
• Cerecetto H, González M. Anti-T. cruzi agents: our experience in the evaluation of more than five hundred compounds. Mini Rev Med Chem 2008;8:1355–1383.
   PubMedGoogle Scholar
• Alvarez G, Aguirre-López B, Varela J, Cabrera M, Merlino A, López GV et al. Massive screening yields novel and selective Trypanosoma cruzi triosephosphate isomerase dimer-interface-irreversible inhibitors with anti-trypanosomal activity. Eur J Med Chem 2010;45:5767–5772.
   PubMedGoogle Scholar
• Ostoa-Saloma P, Garza-Ramos G, Ramírez J, Becker I, Berzunza M, Landa A et al. Cloning, expression, purification and characterization of triosephosphate isomerase from Trypanosoma cruzi. Eur J Biochem 1997;244:700–705.
   PubMedGoogle Scholar
• Borchert TV, Pratt K, Zeelen JP, Callens M, Noble ME, Opperdoes FR et al. Overexpression of trypanosomal triosephosphate isomerase in Escherichia coli and characterisation of a dimer-interface mutant. Eur J Biochem 1993;211:703–710.
   PubMedGoogle Scholar
• Kohl L, Callens M, Wierenga RK, Opperdoes FR, Michels PA. Triose-phosphate isomerase of Leishmania mexicana mexicana. Cloning and characterization of the gene, overexpression in Escherichia coli and analysis of the protein. Eur J Biochem 1994;220:331–338.
   PubMedGoogle Scholar
• García-Torres I, Cabrera N, Torres-Larios A, Rodríguez-Bolaños M, Díaz-Mazariegos S, Gómez-Puyou A et al. Identification of amino acids that account for long-range interactions in two triosephosphate isomerases from pathogenic trypanosomes. PLoS ONE 2011;6:e18791.
   PubMedGoogle Scholar
• Zomosa-Signoret V, Aguirre-López B, Hernández-Alcántara G, Pérez-Montfort R, de Gómez-Puyou MT, Gómez-Puyou A. Crosstalk between the subunits of the homodimeric enzyme triosephosphate isomerase. Proteins 2007;67:75–83.
   PubMedGoogle Scholar
• Pace CN, Vajdos F, Fee L, Grimsley G, Gray T. How to measure and predict the molar absorption coefficient of a protein. Protein Sci 1995;4:2411–2423.
   PubMed Web of Science ®Google Scholar
• Rhoads TW, Lopez NI, Zollinger DR, Morré JT, Arbogast BL, Maier CS et al. Measuring copper and zinc superoxide dismutase from spinal cord tissue using electrospray mass spectrometry. Anal Biochem 2011;415:52–58.
   PubMedGoogle Scholar
• Spartan’04; Wavefunction, Inc. 18401 Von Karman Avenue, Suite 370. Irvine, California 92612 USA.
   Google Scholar
• Crommelin DJA, Schreier H. (1994) Liposomes. In: Kreuter J, ed. Colloidal Drug Delivery Systems. New York: Marcel Dekker, 73–190.
   Google Scholar
• Benitez D, Cabrera M, Hernández P, Boiani L, Lavaggi ML, Di Maio R et al. 3-Trifluoromethylquinoxaline N,N’-dioxides as anti-trypanosomatid agents. Identification of optimal anti-T. cruzi agents and mechanism of action studies. J Med Chem 2011;54:3624–3636.
   PubMed Web of Science ®Google Scholar
• Téllez-Valencia A, Avila-Ríos S, Pérez-Montfort R, Rodríguez-Romero A, Tuena de Gómez-Puyou M, López-Calahorra F et al. Highly specific inactivation of triosephosphate isomerase from Trypanosoma cruzi. Biochem Biophys Res Commun 2002;295:958–963.
   PubMed Web of Science ®Google Scholar
• Zomosa-Signoret V, Hernández-Alcántara G, Reyes-Vivas H, Martínez-Martínez E, Garza-Ramos G, Pérez-Montfort R et al. Control of the reactivation kinetics of homodimeric triosephosphate isomerase from unfolded monomers. Biochemistry 2003;42:3311–3318.
   PubMedGoogle Scholar